DISTINCTIVE

seconD- line folfiri aflIbercept in proSpecTIvely stratified, anti-egfr resistaNt, metastatic coloreCTal  cancer patIents with ras validated wild typE status (distinctive)

AFLIBERCEPT POST ANTI-EGFR IN CCR

· NEWSLETTER

DIST_NEWS.pdf

Scarica il file  

· WCGI 2018

DISTINCTIVE POSTER.pptx

Scarica il file  

· SINOSSI

SINOSSI_DISTINCTIVE.pdf

Scarica il file